Home › Morbo di Alzheimer › Florida › The Villages
Studi clinici su Morbo di Alzheimer a The Villages, FL
15 studi su Morbo di Alzheimer cercano partecipanti presso sedi a The Villages e dintorni (entro circa 30 miglia). Apri uno studio per vedere chi può partecipare e come contattare il team.
Testo ufficiale dello studio (inglese)
Stai reclutando per uno studio? Mettilo in evidenza in cima alla pagina — $99 per 30 giorni →
A Study to Evaluate the Drug Levels, Absolute Bioavailability, Safety, Tolerability, and Immunogenicity of Single-Dose of BMS-986446 in Healthy Adults After Single-dose Administration, and Participants With Early Alzheimer's Disease After Multiple Dose Administration
In reclutamentoFase 1Volontari sani benvenuti
- Local Institution - 0006, The Villages
A Study to Investigate the Safety and Effectiveness of SAR448851 in Participants With Early Alzheimer's Disease
In reclutamentoFase 2
- Charter Research - Lady Lake- Site Number : 8400004, The Villages
A Study to Evaluate KarXT as a Treatment for Psychosis Associated With Alzheimer's Disease (ADEPT-4)
In reclutamentoFase 3
- Charter Research, The Villages
Screening Study to Determine Individuals With Potential Trial Eligibility for Alzheimer's Disease Studies
In reclutamentoFase 3
- Charter Research - Lady Lake/The Villages, The Villages
- K2 Medical Research - The Villages, Lady Lake · a 3 mi di distanza
A Study to Assess the Safety and Effects of ABBV-1758 Following Subcutaneous or Intravenous Injections in Participants With Alzheimer's Disease
In reclutamentoFase 1/2
- K2 Medical Research - The Villages /ID# 278290, Lady Lake · a 3 mi di distanza
A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's Disease (MINDSET 2)
In reclutamentoFase 3
- Local Institution - 0129, The Villages
- K2 MEDICAL Research THE VILLAGES, Lady Lake · a 3 mi di distanza
Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986368, for the Treatment of Agitation in Participants With Alzheimer's Disease
In reclutamentoFase 2
- Charter Research - Lady Lake, The Villages
A Clinical Study of MK-2214 in People With Early Alzheimer's Disease (MK-2214-004)
In reclutamentoFase 2
- Charter Research - Lady Lake ( Site 1019), The Villages
A First-In-Human Study of LY3954068 in Participants With Early Symptomatic Alzheimer's Disease
In reclutamentoFase 1
- Charter Research, LLC, The Villages
A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's Disease
In reclutamentoFase 3
- Charter Research - Lady Lake, The Villages
A Study to Assess the Effects of ACI-24.060 in Alzheimer's Disease and in Down Syndrome (ABATE Study)
In reclutamentoFase 1/2
- Charter Research, LLC, The Villages
- K2 Medical Research The Villages LLC, Lady Lake · a 3 mi di distanza
A Study of Donanemab (LY3002813) in Participants Who Completed Study AACM (TRAILBLAZER-ALZ 3-EXT).
In reclutamentoFase 3
- Charter Research - The Villages, The Villages
A Clinical Trial to Learn About the Effects of VHB937 in People With Early Alzheimer's Disease
In reclutamentoFase 2
- Charter Research The Villages, The Villages
A Study of LY4006895 in Healthy Participants With Early Symptomatic Alzheimer's Disease (AD)
In reclutamentoFase 1Volontari sani benvenuti
- K2 Medical Research - The Villages, Lady Lake · a 3 mi di distanza
[18F]PI-2620 Phase 3 Histopathological Study
In reclutamentoFase 3
- K2 Medical Research, Lady Lake · a 3 mi di distanza
Studi su Morbo di Alzheimer in altre città
- Boston, MA26 studi
- Orlando, FL25 studi
- St. Louis, MO22 studi
- New York City, NY21 studi
- Miami, FL20 studi
- Tampa, FL17 studi
- Atlanta, GA16 studi
- Philadelphia, PA15 studi
- Phoenix, AZ15 studi
- Indianapolis, IN14 studi
- Los Angeles, CA14 studi
- West Palm Beach, FL13 studi
Altri studi a The Villages
- Obesità9 studi
- Sovrappeso8 studi
- Demenza6 studi
- Lieve compromissione cognitiva4 studi
- Malattia epatica steatosica3 studi
- Morbo di Parkinson3 studi
Fonte: ClinicalTrials.gov, dati recuperati il 6 ott 2026. Ogni studio stabilisce i propri criteri di idoneità; è il team di ricerca a decidere chi può partecipare.